Clinical Trials Logo

Generalized Myasthenia Gravis clinical trials

View clinical trials related to Generalized Myasthenia Gravis.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT04777734 Approved for marketing - Clinical trials for Generalized Myasthenia Gravis

Efgartigimod Expanded Access for Generalized Myasthenia Gravis

Start date: n/a
Phase:
Study type: Expanded Access

This expanded access protocol applies to patients with gMG who are not enrolled in an ongoing clinical trial. The aim of the trial is to provide patients with generalized myasthenia gravis (gMG), who are ineligible to participate in a clinical trial, access to efgartigimod treatment before regulatory approval. There are country-specific protocols and also individual use EAP. Recruitment for the treatment protocol in US is now closed (ARGX-113-EAP-2101).